IKT vs REGN: Which Stock is Better?
Side-by-side comparison of Inhibikase Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026
IKT
Inhibikase Therapeutics Inc
$1.76
REGN
Regeneron Pharmaceuticals Inc
$742.08
Key Metrics Comparison
| Metric | IKT | REGN | Winner |
|---|---|---|---|
| Market Cap | $225.78M | $79.87B | REGN |
| P/E Ratio | N/A | 18.21 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | -1.0% | 0.0% | REGN |
| Gross Margin | -3062780800.0% | 44.6% | REGN |
Analyze IKT
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IKT or REGN a better investment?
Comparing IKT and REGN: Inhibikase Therapeutics Inc has a market cap of $225.78M while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IKT and REGN?
IKT (Inhibikase Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IKT or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IKT or REGN?
REGN has higher revenue growth at 0.0% vs -1.0% for IKT.
Which company is more profitable: IKT or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -3062780800.0% for IKT.
Which is the larger company: IKT or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $225.78M for IKT.
Should I buy IKT or REGN in 2026?
Both IKT and REGN have investment merit. IKT trades at $1.76 while REGN trades at $742.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IKT and REGN stock?
Key differences: Market Cap ($225.78M vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (-3062780800.0% vs 44.6%).